Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
7.20
+0.12 (1.69%)
May 9, 2025, 9:48 AM - Market open
Teladoc Health Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Teladoc Health stock have an average target of 9.71, with a low estimate of 7.00 and a high estimate of 12. The average target predicts an increase of 34.86% from the current stock price of 7.20.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Teladoc Health stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 13 | 13 | 11 | 11 | 12 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 18 | 18 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +11.11% | May 8, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +66.67% | May 1, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $13 → $10 | Strong Buy | Maintains | $13 → $10 | +38.89% | May 1, 2025 |
| Stifel | Stifel | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +11.11% | May 1, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | -2.78% | May 1, 2025 |
Financial Forecast
Revenue This Year
2.57B
from 2.57B
Decreased by -0.06%
Revenue Next Year
2.61B
from 2.57B
Increased by 1.60%
EPS This Year
-0.95
from -5.87
EPS Next Year
-0.86
from -0.95
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.7B | 2.8B | 2.9B | ||
| Avg | 2.6B | 2.6B | 2.7B | ||
| Low | 2.4B | 2.4B | 2.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.1% | 7.1% | 9.3% | ||
| Avg | -0.1% | 1.6% | 2.3% | ||
| Low | -5.2% | -6.4% | -8.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.74 | -0.41 | 1.21 | ||
| Avg | -0.95 | -0.86 | -0.58 | ||
| Low | -1.34 | -1.37 | -1.29 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.